Alira Health welcomes Paolo Morgese as Vice President, Market Access Paolo will lead the market access activities for Alira Health and manage the [...]

The United States is the most important Pharma and Med Device market in the world, worth over $600 billion combined. For many Spanish and Italian [...]

Rescuing a clinical trial: strategies for identifying and correcting issues and ensuring a successful outcome Did you know that 86% of drugs and [...]

Assessing Pre-Commercial Value: Refractory Metastatic Colorectal Cancer (mCRC) Monoclonal Antibody Metastatic Colorectal Cancer (mCRC) is the [...]